FDA Regulated Natural Products: Leveraging IP And Regulatory Requirements To Maximize Possible Return On Investment I Wish I Knew What I Know Now: Conversations With AGG On FDA Issues podcast

Eli Beer is a pioneer, social entrepreneur, President and Founder of United Hatzalah of Israel. In thirty years, the organization has grown to more than 6,500 volunteers who unite together to provide immediate, life-saving care to anyone in need - regardless of race or religion. This community EMS force network treats over 730,000 incidents per year, in Israel, as they wait for ambulances and medical attention. Eli’s vision is to bring this life-saving model across the world. In 2015, Beer expanded internationally with the establishment of branches in South America and other countries, including “United Rescue” in Jersey City, USA, where the response time was reduced to just two minutes and thirty-five seconds. Episode Chapters (0:00) intro (1:04) Hatzalah’s reputation for speed (4:48) Hatzalah’s volunteer EMTs and ambucycles (5:50) Entrepreneurism at Hatzalah (8:09) Chutzpah (14:15) Hatzalah’s recruitment (18:31) Volunteers from all walks of life (22:51) Having COVID changed Eli’s perspective (26:00) operating around the world amid antisemitism (28:06) goodbye For video episodes, watch on www.youtube.com/@therudermanfamilyfoundation Stay in touch: X: @JayRuderman | @RudermanFdn LinkedIn: Jay Ruderman | Ruderman Family Foundation Instagram: All About Change Podcast | Ruderman Family Foundation To learn more about the podcast, visit https://allaboutchangepodcast.com/ Looking for more insights into the world of activism? Be sure to check out Jay’s brand new book, Find Your Fight , in which Jay teaches the next generation of activists and advocates how to step up and bring about lasting change. You can find Find Your Fight wherever you buy your books, and you can learn more about it at www.jayruderman.com .…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues « »

FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment

۴ سال پیش 39:58

اشتراک گذاری

محتوای ارائه شده توسط Arnall Golden Gregory LLP. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Arnall Golden Gregory LLP یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

In this episode, partner Kevin M. Bell and of counsel Bob Durkin discuss some of the more interesting issues and challenges they have encountered when working with clients to ensure they maximized opportunities to monetize the greatest value from their natural products and how a well thought out and executed regulatory strategy can help.

9 قسمت

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Tell Me Lies, Tell Me Sweet Little Lies: FDA Is Not My Only Potential Headache When It Comes to Product Promotion 29:29

۲ years پیش29:29

29:29

In this episode, Alan G. Minsk , AGG Food & Drug team leader, and Anuj Desai , AGG Intellectual Property partner and head of Trademarks, discuss recent developments that remind our audience in the food and drug space that FDA is not the only regulatory agency that’s keeping an eye on the marketplace. Alan and Anuj look at how NAD, a BBB program that supports advertising self-regulation, recently addressed a challenge in the prescription drug space. They also talk about how FTC investigative priorities in the past several months may be relevant to the food and drug/life sciences space.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Business Divorces in the Food and Supplements Space 23:13

۴ years پیش23:13

23:13

In this episode, Michael E. Burke , partner and co-chair of the Pharmaceutical & Biotechnology industry team is joined by Robert Durkin , an attorney in our Dietary Supplements team, as they discuss issues around business divorces or disputes between companies in the food and supplements space. They will discuss, among other things, post-divorce product regulatory status and related business challenges, as well as strategies that can be employed at the beginning of the business relationship to help mitigate risk if the relationship goes bad.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Fee Waivers for Small Businesses: Who Qualifies for the Small Business User Fee Waiver for Drugs and Biologics and How to Apply from an FDA and Corporate Perspective 12:31

۴ years پیش12:31

12:31

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk , and Genevieve M. Razick , an attorney in our Healthcare and Food & Drug practices, along with Leah D. Braukman , an attorney in our Corporate & Finance practice, discuss the specifics of the small business user fee waiver, who qualifies, and how to apply from an FDA and corporate perspective.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Data Privacy Issues Life Sciences Companies May Encounter 19:47

۴ years پیش19:47

19:47

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk , and co-chair of AGG’s Data Privacy practice, Kevin L. Coy , discuss U.S. and international privacy and data security law issues life sciences companies may encounter such as privacy policies, the patchwork of federal and state privacy and data security laws in the U.S., international data protection laws, such as GDPR, and related international data transfer issues.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
FDA Regulation of Rx Drug and Medical Device Advertising and Promotion: 2020 Year in Review 20:31

۴ years پیش20:31

20:31

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk , and team member, Genevieve M. Razick , give an overview of FDA’s Office of Prescription Drug Promotion’s (OPDP) enforcement of unlawful advertising in 2020.

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment 39:58

۴ years پیش39:58

39:58

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Pandemic Marketing 101: Do’s and Don’ts to Market Your Brands, Products, and Services Safely 28:51

۴ years پیش28:51

28:51

In this episode, partner Anuj Desai and of counsel Carolina M. Wirth discuss the Federal Trade Commission (FTC) and Food and Drug Administration's (FDA) roles of protecting consumers at the height of a public health crisis and the types of advertising and legal compliance issues that have surfaced in the past several months as well as provide a recap of agency actions.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products 24:31

۵ years پیش24:31

24:31

In this episode, Alan G. Minsk , partner and leader of the Food & Drug practice team, is joined by Brian A. Teras , partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process.…

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues

1
Quality Agreements for FDA-Regulated Products: Looking Under the Hood 27:21

۵ years پیش27:21

27:21

In our inaugural episode, Alan G. Minsk , partner and leader of the Food & Drug practice team, is joined by Michael E. Burke , co-chair of the Pharmaceuticals & Biologics industry team. They discuss issues around quality agreements for FDA regulated products as well as topics related to manufacturing, FDA timelines and compliance with relevant national authorities.…

پادکست هایی که ارزش شنیدن دارند

1
Eli Beer & United Hatzalah: Saving Lives in 90 seconds or Less 30:20

I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues « »
FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment